HEADER HYDROLASE 10-JAN-19 6QFG TITLE CRYSTAL STRUCTURE OF HUMAN KALLIKREIN 6 (I218Y) IN COMPLEX WITH GSK144 COMPND MOL_ID: 1; COMPND 2 MOLECULE: KALLIKREIN-6; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: NEUROSIN,PROTEASE M,SP59,SERINE PROTEASE 18,SERINE PROTEASE COMPND 5 9,ZYME; COMPND 6 EC: 3.4.21.-; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: KLK6, PRSS18, PRSS9; SOURCE 6 EXPRESSION_SYSTEM: BACULOVIRUS EXPRESSION VECTOR PFASTBAC1-HM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 274590 KEYWDS PROTEASE, INHIBITOR, COMPLEX, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR J.H.THORPE REVDAT 3 24-JAN-24 6QFG 1 REMARK REVDAT 2 15-MAY-19 6QFG 1 JRNL REVDAT 1 08-MAY-19 6QFG 0 JRNL AUTH J.H.THORPE,E.V.EDGAR,K.J.SMITH,X.Q.LEWELL,M.RELLA,G.V.WHITE, JRNL AUTH 2 O.POLYAKOVA,P.NASSAU,A.L.WALKER,D.S.HOLMES,A.C.PEARCE, JRNL AUTH 3 Y.WANG,J.LIDDLE,A.HOVNANIAN JRNL TITL EVALUATION OF A CRYSTALLOGRAPHIC SURROGATE FOR KALLIKREIN 5 JRNL TITL 2 IN THE DISCOVERY OF NOVEL INHIBITORS FOR NETHERTON SYNDROME. JRNL REF ACTA CRYSTALLOGR.,SECT.F V. 75 385 2019 JRNL REFN ESSN 2053-230X JRNL PMID 31045568 JRNL DOI 10.1107/S2053230X19003169 REMARK 2 REMARK 2 RESOLUTION. 1.68 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.68 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 58.29 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.2 REMARK 3 NUMBER OF REFLECTIONS : 51113 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.193 REMARK 3 R VALUE (WORKING SET) : 0.191 REMARK 3 FREE R VALUE : 0.219 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 2454 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.68 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.72 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 62.56 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2505 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2229 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2376 REMARK 3 BIN R VALUE (WORKING SET) : 0.2230 REMARK 3 BIN FREE R VALUE : 0.2200 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.15 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 129 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3415 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 72 REMARK 3 SOLVENT ATOMS : 350 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.11 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.23 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.18920 REMARK 3 B22 (A**2) : -3.94010 REMARK 3 B33 (A**2) : -0.24910 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 5.27400 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.240 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.111 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.105 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.107 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.103 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.948 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.939 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3607 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4909 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1203 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 86 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 526 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3607 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 447 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4267 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.09 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.79 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.62 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6QFG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-JAN-19. REMARK 100 THE DEPOSITION ID IS D_1292100092. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-MAY-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97625 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.6.2 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 51138 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.680 REMARK 200 RESOLUTION RANGE LOW (A) : 58.320 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.4 REMARK 200 DATA REDUNDANCY : 2.800 REMARK 200 R MERGE (I) : 0.03900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.68 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.72 REMARK 200 COMPLETENESS FOR SHELL (%) : 63.6 REMARK 200 DATA REDUNDANCY IN SHELL : 1.70 REMARK 200 R MERGE FOR SHELL (I) : 0.43400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1LO6 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.64 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.44 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM TRIS-HCL PH 8.6, PEG 4000 18 REMARK 280 -28%, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 22.95000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS B 245 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 71 -49.94 -132.59 REMARK 500 SER A 195 134.27 -38.61 REMARK 500 SER A 214 -67.78 -125.31 REMARK 500 HIS B 71 -53.69 -133.40 REMARK 500 SER B 195 133.72 -36.14 REMARK 500 SER B 214 -67.24 -122.21 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue J08 A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue J08 B 302 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6QFE RELATED DB: PDB REMARK 900 SAME LIGAND FOR ASSOCIATED PROTEASE REMARK 900 RELATED ID: 6QFF RELATED DB: PDB REMARK 900 SAME LIGAND FOR ASSOCIATED PROTEASE DBREF 6QFG A 16 245 UNP Q92876 KLK6_HUMAN 22 244 DBREF 6QFG B 16 245 UNP Q92876 KLK6_HUMAN 22 244 SEQADV 6QFG GLY A 74 UNP Q92876 ARG 78 ENGINEERED MUTATION SEQADV 6QFG GLN A 76 UNP Q92876 ARG 80 ENGINEERED MUTATION SEQADV 6QFG GLN A 132 UNP Q92876 ASN 134 ENGINEERED MUTATION SEQADV 6QFG TYR A 218 UNP Q92876 ILE 216 ENGINEERED MUTATION SEQADV 6QFG GLY B 74 UNP Q92876 ARG 78 ENGINEERED MUTATION SEQADV 6QFG GLN B 76 UNP Q92876 ARG 80 ENGINEERED MUTATION SEQADV 6QFG GLN B 132 UNP Q92876 ASN 134 ENGINEERED MUTATION SEQADV 6QFG TYR B 218 UNP Q92876 ILE 216 ENGINEERED MUTATION SEQRES 1 A 223 LEU VAL HIS GLY GLY PRO CYS ASP LYS THR SER HIS PRO SEQRES 2 A 223 TYR GLN ALA ALA LEU TYR THR SER GLY HIS LEU LEU CYS SEQRES 3 A 223 GLY GLY VAL LEU ILE HIS PRO LEU TRP VAL LEU THR ALA SEQRES 4 A 223 ALA HIS CYS LYS LYS PRO ASN LEU GLN VAL PHE LEU GLY SEQRES 5 A 223 LYS HIS ASN LEU GLY GLN GLN GLU SER SER GLN GLU GLN SEQRES 6 A 223 SER SER VAL VAL ARG ALA VAL ILE HIS PRO ASP TYR ASP SEQRES 7 A 223 ALA ALA SER HIS ASP GLN ASP ILE MET LEU LEU ARG LEU SEQRES 8 A 223 ALA ARG PRO ALA LYS LEU SER GLU LEU ILE GLN PRO LEU SEQRES 9 A 223 PRO LEU GLU ARG ASP CYS SER ALA GLN THR THR SER CYS SEQRES 10 A 223 HIS ILE LEU GLY TRP GLY LYS THR ALA ASP GLY ASP PHE SEQRES 11 A 223 PRO ASP THR ILE GLN CYS ALA TYR ILE HIS LEU VAL SER SEQRES 12 A 223 ARG GLU GLU CYS GLU HIS ALA TYR PRO GLY GLN ILE THR SEQRES 13 A 223 GLN ASN MET LEU CYS ALA GLY ASP GLU LYS TYR GLY LYS SEQRES 14 A 223 ASP SER CYS GLN GLY ASP SER GLY GLY PRO LEU VAL CYS SEQRES 15 A 223 GLY ASP HIS LEU ARG GLY LEU VAL SER TRP GLY ASN TYR SEQRES 16 A 223 PRO CYS GLY SER LYS GLU LYS PRO GLY VAL TYR THR ASN SEQRES 17 A 223 VAL CYS ARG TYR THR ASN TRP ILE GLN LYS THR ILE GLN SEQRES 18 A 223 ALA LYS SEQRES 1 B 223 LEU VAL HIS GLY GLY PRO CYS ASP LYS THR SER HIS PRO SEQRES 2 B 223 TYR GLN ALA ALA LEU TYR THR SER GLY HIS LEU LEU CYS SEQRES 3 B 223 GLY GLY VAL LEU ILE HIS PRO LEU TRP VAL LEU THR ALA SEQRES 4 B 223 ALA HIS CYS LYS LYS PRO ASN LEU GLN VAL PHE LEU GLY SEQRES 5 B 223 LYS HIS ASN LEU GLY GLN GLN GLU SER SER GLN GLU GLN SEQRES 6 B 223 SER SER VAL VAL ARG ALA VAL ILE HIS PRO ASP TYR ASP SEQRES 7 B 223 ALA ALA SER HIS ASP GLN ASP ILE MET LEU LEU ARG LEU SEQRES 8 B 223 ALA ARG PRO ALA LYS LEU SER GLU LEU ILE GLN PRO LEU SEQRES 9 B 223 PRO LEU GLU ARG ASP CYS SER ALA GLN THR THR SER CYS SEQRES 10 B 223 HIS ILE LEU GLY TRP GLY LYS THR ALA ASP GLY ASP PHE SEQRES 11 B 223 PRO ASP THR ILE GLN CYS ALA TYR ILE HIS LEU VAL SER SEQRES 12 B 223 ARG GLU GLU CYS GLU HIS ALA TYR PRO GLY GLN ILE THR SEQRES 13 B 223 GLN ASN MET LEU CYS ALA GLY ASP GLU LYS TYR GLY LYS SEQRES 14 B 223 ASP SER CYS GLN GLY ASP SER GLY GLY PRO LEU VAL CYS SEQRES 15 B 223 GLY ASP HIS LEU ARG GLY LEU VAL SER TRP GLY ASN TYR SEQRES 16 B 223 PRO CYS GLY SER LYS GLU LYS PRO GLY VAL TYR THR ASN SEQRES 17 B 223 VAL CYS ARG TYR THR ASN TRP ILE GLN LYS THR ILE GLN SEQRES 18 B 223 ALA LYS HET GOL A 301 6 HET J08 A 302 30 HET GOL B 301 6 HET J08 B 302 30 HETNAM GOL GLYCEROL HETNAM J08 4-[(5-PHENYL-1~{H}-IMIDAZOL-2-YL)METHYLAMINO]-2- HETNAM 2 J08 (PYRIDIN-3-YLMETHOXY)BENZENECARBOXIMIDAMIDE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 GOL 2(C3 H8 O3) FORMUL 4 J08 2(C23 H22 N6 O) FORMUL 7 HOH *350(H2 O) HELIX 1 AA1 ALA A 55 LYS A 59 5 5 HELIX 2 AA2 SER A 164 TYR A 172 1 9 HELIX 3 AA3 TYR A 234 ALA A 244 1 11 HELIX 4 AA4 ALA B 55 LYS B 59 5 5 HELIX 5 AA5 SER B 164 TYR B 172 1 9 HELIX 6 AA6 TYR B 234 ALA B 244 1 11 SHEET 1 AA1 8 GLY A 20 PRO A 21 0 SHEET 2 AA1 8 GLN A 156 VAL A 163 -1 O CYS A 157 N GLY A 20 SHEET 3 AA1 8 MET A 180 GLY A 184 -1 O GLY A 184 N HIS A 161 SHEET 4 AA1 8 GLY A 226 ASN A 230 -1 O TYR A 228 N LEU A 181 SHEET 5 AA1 8 HIS A 208 TRP A 215 -1 N TRP A 215 O VAL A 227 SHEET 6 AA1 8 PRO A 198 CYS A 201 -1 N LEU A 199 O ARG A 210 SHEET 7 AA1 8 CYS A 136 GLY A 140 -1 N HIS A 137 O VAL A 200 SHEET 8 AA1 8 GLN A 156 VAL A 163 -1 O GLN A 156 N GLY A 140 SHEET 1 AA2 7 GLN A 30 THR A 35 0 SHEET 2 AA2 7 HIS A 39 HIS A 48 -1 O LEU A 41 N LEU A 33 SHEET 3 AA2 7 TRP A 51 THR A 54 -1 O LEU A 53 N VAL A 45 SHEET 4 AA2 7 MET A 104 LEU A 108 -1 O LEU A 106 N VAL A 52 SHEET 5 AA2 7 GLU A 81 ILE A 90 -1 N VAL A 89 O LEU A 105 SHEET 6 AA2 7 GLN A 64 LEU A 67 -1 N VAL A 65 O SER A 83 SHEET 7 AA2 7 GLN A 30 THR A 35 -1 N TYR A 34 O GLN A 64 SHEET 1 AA3 8 GLY B 20 PRO B 21 0 SHEET 2 AA3 8 GLN B 156 VAL B 163 -1 O CYS B 157 N GLY B 20 SHEET 3 AA3 8 MET B 180 GLY B 184 -1 O GLY B 184 N HIS B 161 SHEET 4 AA3 8 GLY B 226 ASN B 230 -1 O TYR B 228 N LEU B 181 SHEET 5 AA3 8 HIS B 208 TRP B 215 -1 N TRP B 215 O VAL B 227 SHEET 6 AA3 8 PRO B 198 CYS B 201 -1 N LEU B 199 O GLY B 211 SHEET 7 AA3 8 SER B 135 GLY B 140 -1 N HIS B 137 O VAL B 200 SHEET 8 AA3 8 GLN B 156 VAL B 163 -1 O ILE B 160 N CYS B 136 SHEET 1 AA4 7 GLN B 30 THR B 35 0 SHEET 2 AA4 7 HIS B 39 HIS B 48 -1 O CYS B 42 N LEU B 33 SHEET 3 AA4 7 TRP B 51 THR B 54 -1 O LEU B 53 N VAL B 45 SHEET 4 AA4 7 MET B 104 LEU B 108 -1 O LEU B 106 N VAL B 52 SHEET 5 AA4 7 GLU B 81 ILE B 90 -1 N VAL B 89 O LEU B 105 SHEET 6 AA4 7 LEU B 63 LEU B 67 -1 N LEU B 67 O GLU B 81 SHEET 7 AA4 7 GLN B 30 THR B 35 -1 N TYR B 34 O GLN B 64 SSBOND 1 CYS A 22 CYS A 157 1555 1555 2.02 SSBOND 2 CYS A 42 CYS A 58 1555 1555 2.03 SSBOND 3 CYS A 128 CYS A 232 1555 1555 2.05 SSBOND 4 CYS A 136 CYS A 201 1555 1555 2.05 SSBOND 5 CYS A 168 CYS A 182 1555 1555 2.03 SSBOND 6 CYS A 191 CYS A 220 1555 1555 2.05 SSBOND 7 CYS B 22 CYS B 157 1555 1555 2.03 SSBOND 8 CYS B 42 CYS B 58 1555 1555 2.04 SSBOND 9 CYS B 128 CYS B 232 1555 1555 2.06 SSBOND 10 CYS B 136 CYS B 201 1555 1555 2.02 SSBOND 11 CYS B 168 CYS B 182 1555 1555 2.01 SSBOND 12 CYS B 191 CYS B 220 1555 1555 2.06 CISPEP 1 TYR A 218 PRO A 219 0 -2.18 CISPEP 2 TYR B 218 PRO B 219 0 -2.07 SITE 1 AC1 8 PRO A 92 ASP A 93 HOH A 414 HOH A 492 SITE 2 AC1 8 TYR B 34 PHE B 66 LYS B 70 LEU B 73 SITE 1 AC2 14 HIS A 57 HIS A 99 ASP A 189 SER A 190 SITE 2 AC2 14 CYS A 191 SER A 195 VAL A 213 SER A 214 SITE 3 AC2 14 TRP A 215 GLY A 216 ASN A 217 TYR A 218 SITE 4 AC2 14 CYS A 220 HOH A 463 SITE 1 AC3 6 GLU B 167 GLY B 184 ASP B 185 SER B 221 SITE 2 AC3 6 LYS B 222 PRO B 225 SITE 1 AC4 16 GLY A 38 HIS A 39 HIS B 57 HIS B 99 SITE 2 AC4 16 ASP B 189 SER B 190 CYS B 191 SER B 195 SITE 3 AC4 16 VAL B 213 SER B 214 TRP B 215 GLY B 216 SITE 4 AC4 16 ASN B 217 TYR B 218 CYS B 220 HOH B 480 CRYST1 58.400 45.900 89.350 90.00 93.64 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017123 0.000000 0.001089 0.00000 SCALE2 0.000000 0.021786 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011215 0.00000